key: cord-0260060-4ikd6gl0
authors: Cavazzoni, Cecilia B.; Bozza, Vicente B. T.; Tostes, Lucas; Maia, Bruno; Mesin, Luka; Schiepers, Ariën; Ersching, Jonatan; Neris, Romulo L.S.; Conde, Jonas N.; Coelho, Diego R.; Conde, Luciana; de Paula Neto, Heitor A.; Lima, Tulio M.; Alvim, Renata G.F.; Castilho, Leda R.; Mohana-Borges, Ronaldo; Assunção-Miranda, Iranaia; Nobrega, Alberto; Victora, Gabriel D.; Vale, Andre M.
title: Sustained antibody response to ZIKV infection induced by NS1 protein is accompanied by the progressive appearance of autoreactive antibodies and cross-reactive B cell clones
date: 2021-03-12
journal: bioRxiv
DOI: 10.1101/2020.12.24.423863
sha: 5e37b056bd216be7a567ea7d9172d59e0a126edd
doc_id: 260060
cord_uid: 4ikd6gl0

Besides antigen-specific responses to viral antigens, humoral immune response in virus infection can generate polyreactive and autoreactive antibodies. Dengue and Zika virus infections have been linked to antibody-mediated autoimmune disorders including Guillain-Barrè syndrome. A unique feature of flaviviruses is the secretion of non-structural protein 1 (NS1) by infected cells. NS1 is highly immunogenic and antibodies targeting NS1 can have both protective and pathogenic roles. In the present study, we investigated the humoral immune response to Zika virus NS1 and found NS1 to be an immunodominant viral antigen associated with the presence of autoreactive antibodies. Through single B cell cultures, we coupled binding assays and BCR sequencing, confirming the immunodominance of NS1. Of note, we demonstrate the presence of self-reactive clones in germinal centers after both infection and immunization, some of which clones presenting cross-reactivity with NS1. Sequence analysis of anti-NS1 B cell clones showed sequence features associated with pathogenic autoreactive antibodies. Our findings demonstrate NS1 immunodominance at the cellular level as well as a potential role for NS1 in ZIKV associated autoimmune manifestations.

The protective function of antibodies is instrumental for the control of most viral infections.

However, in addition to antigen-specific responses to viral antigens, it has long been noted that viral infection can be accompanied by the appearance of polyreactive and often autoreactive antibodies of unknown function [1] . Emergence of self-reactive immunoglobulins has been reported for multiple viral diseases; these autoreactive antibodies have the potential to lead to autoimmune manifestations, which can be transient or long-lasting (reviewed in [2] ).

The origin of the stimulus driving autoantibody generation in viral infection remains controversial. On one hand, antigen mimicry between viral and self-antigens may explain the appearance of selected autoantibodies. Alternatively, a role for cytokine storm leading to nonspecific, polyclonal B cell activation followed by disruption of B cell repertoire homeostasis and self-tolerance has also been proposed [3] .

Recently, dengue virus (DENV) and zika virus (ZIKV) infections have been linked to the occurrence of autoimmune disorders of vascular, ophthalmic or neurological origin, including Guillain-Barrè syndrome [4, 5] , in which autoantibodies seem to play a prominent role [6] . A unique feature of DENV, ZIKV and other flaviviruses is the abundant secretion of the nonstructural protein 1 (NS1) in its hexameric form by infected cells [7] [8] [9] [10] . While intracellular NS1 was shown to be necessary for viral replication, its role as an extracellular soluble factor is poorly understood [11] . It has recently been shown that NS1 can lead to endothelial dysfunction [12] . Moreover, work from multiple groups has shown that NS1 is highly immunogenic [13] [14] [15] . Notably, antibodies to DENV NS1 can attenuate the outcome of severe dengue and vaccination with ZIKV and DENV NS1 have been shown to be protective in animal models [16] [17] [18] [19] . These studies suggest a role for NS1 in the pathogenesis of flavivirus infections, as well as a protective role for anti-NS1 antibodies. However, anti-DENV NS1 antibodies have also been implicated in autoreactivity and may contribute to dengue pathology, possibly through antigen mimicry between NS1 and components of self [20] [21] [22] [23] ;

these observations raise concerns about the safety of NS1 as a vaccine antigen, and further studies are necessary to understand the humoral immune response to this molecule.

Studies of the pathogenesis of human viral infections in animal models face several limitations due to innate viral resistance of mouse species to many human viruses. For this reason, multiple groups have developed models that rely on immunocompromised mice, such as IFNAR-deficient strains, which show greater susceptibility to viral infections [24] [25] [26] [27] .

Although such strategies are useful in studies of viral pathology, they are less useful for the analysis of humoral immune responses, as type-I interferons broadly influence acquired immunity and directly impact activation of B cells by modulating B cell receptor (BCR) signaling [28, 29] possibly also affecting clonal selection and entry into germinal centers (GCs) [30] . For these reasons, an immunocompetent mouse model of ZIKV infection is preferred for the study of antibody response. Accordingly, recent studies have used such models to characterize the T cell [31] [32] [33] and neutralizing antibody response to ZIKV [34] . Using immunocompetent mouse models, we and others have shown that CD4+ T cells activate a robust IFNγdependent B cell response, which is associated with production of neutralizing IgG2a antibodies that bind to ZIKV envelope proteins including envelope protein domain III (EDIII) and have been associated with virus neutralization. Of note, passive transfer of serum from infected immunocompetent A129 mice protected immunocompromised mice against lethal heterologous challenge with ZIKV [35] [36] [37] .

In the present study, we investigated the humoral immune response to ZIKV NS1 using an immunocompetent mouse model of ZIKV infection as well as NS1 immunization. The antibody response in infected animals showed that NS1 is an immunodominant viral antigen.

Importantly, humoral response to NS1 is associated with the presence of autoreactive antibodies, both after infection or immunization. In-depth analysis of B cell clone selection into GCs, coupling single B cell cultures with BCR sequencing confirmed the strong immunodominance of NS1 and revealed the presence of frequent self-reactive clones among GC B cells, some of which were cross-reacted with NS1. Anti-NS1 B cell clones were enriched in charged amino acid residues in the CDR-H3 region, a feature shared by self-reactive clones [38, 39] . Anti-NS1 clones also showed low levels of somatic hypermutation (SHM) possibly indicative of adaptation of the germline repertoire to this antigen. The presence of self-reactive B cell clones in GCs, formed in response to an immunodominant viral antigen, strongly supports a break of tolerance at the cellular level. Taken together, these findings indicate the potential relevance of NS1 for ZIKV pathogenicity and its associated autoimmune manifestations.

To study the humoral immune response to ZIKV infection in immunocompetent mice, we injected young adult BALB/c WT mice intravenously with 10 7 -10 8 PFU of the Brazilian ZIKV isolate PE243 [40] and followed antibody responses for 50 days post-infection (d.p.i) (Fig. 1 A). Mice showed increased spleen weight from day 7 to 28 after infection ( Fig. 1 B) , as well as altered total serum immunoglobulin concentrations. Increased serum IgM was detected at 7 d.p.i. (Fig. 1 C) and total serum IgG concentration increased progressively between 7 and 21 d.p.i., stabilizing at a higher concentration than controls for up to 50 days after infection ( Fig. 1 D) .

Serum IgM binding to envelope proteins peaked at 7 d.p.i. (Fig. 1 E) followed by a peak in IgG at 14 d.p.i., (Fig. 1 F) as detected using Zika virus-like particles (VLPs) that display proteins E and M in their mature form [41] . Domain III of protein E (EDIII) is a target of neutralizing antibodies for different flaviviruses [34, [42] [43] [44] . We therefore also assayed serum for IgG binding to this portion of the E protein. We found that EDIII-specific IgG peaked in serum at 14 d.p.i. (Fig. 1 G) , at which point serum neutralizing activity was also observed (data not shown).

We next searched for NS1-binding IgM and IgG antibodies in sera of infected mice. NS1 is known to be abundantly secreted into the extracellular milieu by flavivirus-infected cells [45] and is highly immunogenic [8] . IgM binding to NS1 remained almost unchanged compared to uninfected controls (Fig. 1 H) . Interestingly, although serum IgG specific to NS1 appeared later than that targeting envelope proteins, anti-NS1 IgG increased progressively after infection, remaining at very high levels for as long as 50 d.p.i. (Fig. 1 I) . Since viral RNA was undetectable in blood and brain tissue, in order to investigate whether our observations were dependent on viral replication leading to secretion of NS1 protein by infected cells, we performed the same experiment with UV-inactivated virus. Mice were injected intravenously with 10 7 -10 8 PFU of UV-inactivated (iZIKV) or replicative ZIKV isolate PE243 [40] and evaluated for 60 days after infection (Fig. S1 A) . UV-inactivated ZIKV did not induce an increase in spleen weight (Fig. S1 B) . Despite the presence of E protein-specific IgG in serum (Fig. S1 C), these immunoglobulins did not target domain III (Fig. S1 D) , and NS1-specific IgG was not detected in serum (Fig. S1 E) . Taken together, these results demonstrate that, although immunocompetent mice survive ZIKV infection with few or no clinical signs, infection with replicative virus induced a robust humoral immune response, which became progressively dominated by antibodies to the NS1 antigen.

The increasing levels of anti-NS1 IgG antibodies from 21 d.p.i. onwards prompted us to further investigate the NS1-specific response in infected mice. Serum titration at different time points suggested an increase in concentration or affinity of IgG for the viral antigen ( Fig. 2 A) .

Endpoint titers increased gradually to approximately 200,000 at the latest time point assayed ( Fig. 2 B) . Serum IgG was predominantly of the IgG2a isotype throughout infection, as expected for anti-viral responses [46] . Of note, there was a late contribution of IgG1 to total serum IgG titer (Fig. 2 C and D) . Given that gamma 1 constant region gene is located upstream of gamma 2a, ruling out sequential switching between these isotypes, our data suggest continued engagement of B cell clones after the initial phase of the response. We also assessed the binding of IgG to closely-related dengue virus antigens. As observed in human antibody response to ZIKV infection [15, 47] , we found cross-reactivity between ZIKV EDIII and DENV EDIII (Fig. 2 E; Fig. S2 , A and B), whereas ZIKV NS1-specific IgG did not crossreact with DENV NS1 protein (Fig. 2 F; Fig. S2 , C and D).

In addition to the presence of virus-specific antibody responses, viral infections are often associated with hyperglobulinemia due to non-specific polyclonal activation of B lymphocytes [1] . To assess the potential of ZIKV infection to induce a polyclonal, non-specific humoral immune response, we looked for IgG binding to unrelated antigens such as heat shock proteins from both mammalian and commensal bacterial origins, which are commonly targeted by autoantibodies in different systems [48-50] (Fig. S2 , E and F). IgG binding to unrelated antigens, possibly due to polyreactivity, was present at early time points and rapidly decayed, following the kinetics of antibody response to viral structural proteins shown in Figure 1 .

Interestingly, serum IgG from ZIKV-infected mice also displayed widespread binding to selfantigens, as revealed using a semiquantitative immunoblot assay that enables global analysis of the self-reactivity of antibodies present in serum [51, 52] . Accordingly, at 14 d.p.i., ZIKVinfected mice exhibited serum IgG reactivity to multiple self-antigens from syngeneic brain and muscle tissues ( To further investigate the progressive increase of self-reactive IgG following infection, we tested serum samples from an additional cohort of ZIKV-infected mice for binding to a HEp-2 cell line extract. These cells are frequently used in standard clinical assays for anti-nuclear antibodies (ANAs), but also as a source of cytoplasmic self-antigens [38] . Consistently, a broad range of immunoreactivities arose over time after infection (Fig. 2 K) . The levels of IgG reactive to a 60 kDa self-antigen paralleled those of NS1-specific, but not of EDIII-specific, IgG over time (Fig. 2 L) . The overlapping kinetics of anti-NS1 response and self-reactive serum IgG led us to hypothesize there could be a link between the maintenance of autoreactive antibodies and a dominant and sustained anti-NS1 antibody response. Viral infections typically induce T-dependent antibody responses, in which follicular B cells   (FO) enter GC reactions where they undergo clonal expansion, SHM, and selection, leading to antibody affinity maturation (reviewed in [53]). After intravenous (i.v.) ZIKV infection, we observed abundant GC formation in spleen. Frequencies of different splenic B cell populations were found to be altered; the reduction in frequency of FO B cells likely reflected GC formation and correlated with levels of serum IgG specific to ZIKV proteins. GC B cell frequency peaked at day 14 after infection and started to decrease by day 21, receding to background levels at 28 d.p.i. (Fig. 3 A) .

To investigate the possible link between the antibody response to NS1 and the presence of self-reactive IgG in serum, we devised an experimental strategy that allowed us to more appropriately compare GC B cells between infected and immunized mice. For that purpose, mice were subcutaneously infected in the footpad with ZIKV and draining lymph nodes (LN) were collected on different days post-infection to isolate GC B cells (Fig. 3 B) . Consistent with our previous results, we found increasing levels of IgG binding to ZIKV NS1 in serum up to 45 days after subcutaneous infection. This increase was not observed when the same amount of UV-inactivated virus (iZIKV) was injected, indicating that this phenomenon requires replicative ZIKV infection (Fig. 3 C) . We could also observe GC formation in LN after both ZIKV infection and iZIKV immunization, although the latter were both of lower magnitude and shorter in duration ( Using limiting dilution analysis (LDA), we were able to estimate the frequency of GC B cells secreting immunoglobulins binding to VLP or NS1 (Fig. 3 , F and G), as well as to selfantigens ( Fig. 3 H) At 14 d.p.i., no reactivity to viral surface antigens was detected in GC B cells derived from control mice (mock) and less than 0.1% of GC B cells from iZIKV-imumunized mice secreted IgG that bound detectably to VLP. Moreover, we were unable to detect GC B cell clones secreting NS1-reactive IgG in neither mock-nor iZIKV-immunized mice (data not shown). On the other hand, in ZIKV-infected mice, GC B cells specific for NS1 were readily detected at relatively high frequencies (Fig. 3 F) . The proportion of GC B cells reacting to NS1 (4.5%) was 10-fold higher than that of GC B cells binding to envelope proteins (0.4%) ( These findings underscore the extent of the immunodominance of NS1 over envelope antigens also at the cellular level.

We then performed the global analysis of self-reactivities, as used for serum IgG (Fig. 2 H), with GC B cell culture supernatants. By combining LDA and immunoblot assays, we were able to estimate the frequency of cell secreting IgG binding to self-antigens in each GC B cell culture (Fig. 3 H) . Our analysis showed that autoreactive B cells were present within GCs formed after exposure to replicative ZIKV, whereas these were virtually absent upon exposure to UV-inactivated virus (Fig. 3 H) . Importantly, the self-reactivity found with highest frequency (Ag2) accounted for 1% of GC B cells in the lymph node ( Fig. 3 H) , at least twice the frequency of GC B cells detectably specific for virus envelope proteins (Fig. 3 G) . These data suggest a role for NS1 in triggering the autoreactive antibody response following ZIKV infection.

To directly test whether an anti-NS1 humoral immune response generates autoreactive antibodies, we immunized mice in the footpads with purified recombinant ZIKV NS1 in the presence of a TLR7 agonist (R848). For comparison, two other groups were included. Mice were immunized with ZIKV virus-like particles (VLPs), displaying envelope proteins (E and M) in the presence of R848 or with a combination of VLPs and NS1 (Fig. 4 A) . We first analyzed the humoral immune response against the viral antigens. We found that, from day 14 postimmunization onwards, serum levels of NS1-specific IgG were higher than those of VLPspecific IgG in both combinations (Fig. 4 B) . Despite the similar frequencies of total GC B cells in popliteal LNs ( Fig. 4 C) , frequencies of specific B cells within the GC varied. At day 14 after immunization with VLP/R848, the frequency of GC B cells binding to VLPs was 2.6% ( Fig. 5 E, left panels). After immunization with NS1/R848, however, frequency of specific GC B cells was approximately 10-fold higher, at 27% (Fig. 4 E, right panels). Compared to the single antigen immunization protocol, VLP and NS1 in combination reduced the frequency of GC B cells specific for both antigens to 1.2% and 3%, respectively. (Fig. 4 E, middle panels). This reduction was not due to lower secretion of IgG in vitro, since similar levels of NS1 specific IgG were found in culture supernatants, irrespective of the presence of VLPs in the immunization (Fig. 4 F) . Altogether, antigen-specific GC B cell frequency and kinetics in immunized mice mirrored the virus-specific IgG levels found in the ZIKV infection model, corroborating the observed immunodominance of NS1 over ZIKV envelope antigens.

To further characterize the B cell response to ZIKV NS1, we sorted single GC B cells from popliteal LNs of mice immunized with this antigen at different time points and performed Igh sequencing. To gain insight into specific features of ZIKV NS1 B cell response, we also immunized mice with DENV NS1 for comparison, since, even though the two proteins are structurally homologous, antibodies generated after infection with ZIKV did not cross-react with DENV NS1 (see Fig. 2 F) . As expected, GCs found in popliteal LNs of mice immunized with either ZIKV or DENV NS1 proteins 10 days post-immunization were highly clonally diverse, whereas clones with increased frequency accumulated over time (Fig. 5A ).

Analysis of VH segment usage showed preferential use of the VH1 (J558) gene family, irrespective of immunizing antigen and time point analyzed (Fig. S4 A) . The average number of mutations in VH gene segments was similar for both antigens and increased over time as one would expect. However, interestingly, VH mutation numbers were lower among clones found more frequently (likely those undergoing positive selection) in GCs formed after ZIKV NS1 immunization when compared to those formed after DENV NS1 immunization ( Fig. 5 B) .

In contrast to those clones from ZIKV NS1 immunization, B cells in GCs from DENV NS1immunized mice tended to progressively accumulate mutations in more expanded clones over time (Fig. 5 C) .

Although no significant differences in CDR-H3 length were found in GC B cells after DENV or ZIKV NS1 immunization at any time point (Fig. S4 B) , there was a preference for 11-amino acid-long CDR-H3s in both ZIKV NS1 and DENV NS1 immunized mice when compared to the naïve B cell repertoire (Fig. S4 C) . Average CDR-H3 hydrophobicity tended to be lower for ZIKV NS1 than for DENV NS1 (Fig. 5 D) . The distribution of CDR-H3 average hydrophobicity revealed few highly charged sequences among B cells responding to ZIKV NS1 antigen ( However, a marked glycine (neutral amino acid) enrichment was also observed, which could counterbalance the charged amino acid bias, resulting in a moderate change in average hydrophobicity in CDR-H3 sequences as shown in Fig. 5 D. Evaluating the percent difference between hydrophobic and charged amino acids in CDR-H3 sequences, we found that B cell clones derived from the ZIVK NS1 immunized animals used charged amino acids more frequently than hydrophobic ones when compared to the DENV NS1-immunized mice (Fig. 5 G).

The recruitment of B cells enriched in charged CDR-H3 sequences into the GCs upon immunization with ZIKV NS1 could be related to the emergence of autoreactive IgG. Although, the specificities of the immunoglobulins encoded by these sequences are not known, results obtained with GC B cells cultures suggest that most of these cells (63% for ZIKV NS1 and 97% for ZIKV VLP) do not secrete antibodies with detectable binding to the antigen used in immunization (see Fig. 4 E). One might expect that the most expanded clones would be those with the greatest affinity for the antigen; however, it remains possible that the most mutated clones would become expanded only at later time points, after more extensive selection, and would therefore not be detected at high frequencies in the samples we analyzed. To better understand this phenomenon, we sought to correlate the features of immunoglobulin variable gene sequences with the specificities of their secreted antibodies.

To understand the relationship between Ig sequence features and antigen specificity, we ongoing GCs (Fig. 6 B) . In contrast, non-binder clones showed significantly less clonal expansion at all time points analyzed ( Fig. 6 B) . Interestingly, and consistent with data shown previously ( Fig. 5 B) , we did not find evidence for positive selection of NS1-binding clones bearing large numbers of somatic mutations (Fig. 6 C) .

We then investigated the physicochemical features of the CDR-H3 sequences expressed by B cells recruited to GCs after ZIKV NS1 immunization. On day 14 p.i., both ZIKV NS1 binders and non-binders showed similar CDR-H3 hydrophobicity, whereas on day 21 p.i., ZIKV NS1 binders tended to be less charged and closer to neutrality than non-binders, an effect just short of statistical significance (Fig. 6 D) . To examine whether NS1 binding correlated with the abundance of positively charged amino acids in CDR-H3, we plotted the anti-NS1 reactivity per clone at each time point, highlighting CDR-H3s expressing three or more charged amino acids ( Fig. 6 E, red dots). CDR-H3 sequences bearing charged amino acids were frequent and evenly distributed among NS1-binder and non-binder clones, accounting for 25% to 35% of CDR-H3 sequences (Fig. 6 E) The presence of positively charged amino acids within CDR-H3 is a common feature associated with self-reactivity [59]. To determine whether particular Igh sequence features were correlated with self-reactivity, we tested 58 monoclonal antibodies for binding to autologous muscle and brain extracts (Table S1 and were self-reactive. This frequency increased to 42.3% of the analyzed cells from 21 d.p.i.

Highly charged CDR-H3 were not determinant for self-reactivity since we found this feature among both self-reactive and non-self-reactive clones. Nevertheless, we did find a handful of clonotypes bearing hydrophobic amino acids in their CDR-H3 that were predominantly selfreactive (Table S1 ; Fig. 6 , F and I).

We further analyzed the SHM patterns and clonal frequencies of 58 GC B cells for which we obtained complete data set, correlating it with IgG reactivity to NS1 and to self-antigens.

Among GC B cells obtained at day 14 after immunization with ZIKV NS1, we found cells with similar CDR-H3 but different SHM patterns, including a clonal family bearing a "glycineenriched CDR-H3" (ARGGGYDGFAY). The least mutated cell in this group was inferred to have acquired a non-silent mutation in the D2-02 gene segment, which led to the replacement of a tyrosine by a phenylalanine in the CDR-H3 (becoming ARGGGFDGFAY). The germline D2-02 D gene segment encodes the GYD motif, whereas the mutated version encoded a GFD motif, which displayed increased poly-reactivity against self-antigens together with increased reactivity to ZNS1 ( Fig. S5 A and Table S1 ). The two clones bearing the glycine-enriched CDR-H3 that bound NS1 and cross-reacted with self-antigens were also highly expanded, suggesting that antigen-specific GC B cells -whether self-reactive or not -are capable of undergoing positive selection ( Fig. 6 G, green dots). At 21 d.p.i., other groups of related clonotypes were found with different SHM patterns (Table S1 and Fig. 6 F ). An interesting autoreactive clone carried the ARGTLYAMDY CDR-H3 ( Fig. 6 F, highlighted in blue colors). In addition to being among the most hydrophobic sequences in our list, we found more mutated variants both non-autoreactive (ARGTLYTMDY) and autoreactive (ARGTLYSMDY) (Fig. S5 B, Fig. 6 F and Table S1 ). Although all variants of this clonal family bound to ZIKV NS1 protein, the most mutated one (ARGTLYSMDY) displayed the highest relative reactivity to NS1 (Table S1 ) as well as increased poly-and selfreactivity ( Fig. S5 B and Fig. 6 F, highlighted in light blue). In this case, only the least mutated sequence (ARGTLYAMDY) was found more than once in the data set. Notably, the two most prominent self-reactivities found in the ARGTLYSMDY clone were also found in serum IgG from mice infected with ZIKV 35 d.p.i. (Fig. S5 B and Fig. 6 F, blue arrows).

Overall, ZIKV NS1 clonotypes found at the highest frequencies (> 5 counts) were generally non-self-reactive ( Fig. 6 G) . Moreover, all NS1-binding immunoglobulins tested for selfreactivity, regardless of their self-reactivity status, had numbers of VH mutations that were similar and higher than those of non-antigen-specific cells, again suggesting antigen-driven selection (Fig. 6 H) . The most mutated clones did not bind to self-antigens and were found exclusively as singletons, irrespective of binding to ZIKV NS1 (Fig. 6 G and H, gray dots) .

The results obtained with single cell sequencing and binding assays were summarized in clones. Interestingly, the decrease in clonal dominance inversely correlated with increased self-reactivity, suggesting a replacement of early clones by a new wave of B cells with selfreactive potential. SHM appeared not to increase from day 14 to 21, which would be in line with clonal replacement. Self-reactive clones were already present at day 14, all of which exhibited cross-reactivity with ZIKV NS1. It is noteworthy that autoreactive clones with no cross-reactivity with NS1 were present at day 21 but not at day 14 p.i.. Although the number of clones assayed for autoreactivity limits the strength of this conclusion, we found more selfreactivity among NS1-binders than among non-binders. Collectively, our data support a role for NS1 in recruiting cross-reactive B cell clones into GCs, some of which are self-reactive clonotypes showing evidence for clonal expansion and paucity of VH gene mutations.

The humoral immune response to ZIKV infection in humans is characterized by early appearance of antibodies to structural proteins of the viral envelope followed by a later increase in antibodies to the non-structural protein NS1 [14, 15] . Here, we found that the humoral immune response of immunocompetent BALB/c mice to ZIKV infection follows a similar pattern. The BALB/c antibody response is characterized by early emergence of envelope-specific IgG, including EDIII-specific and neutralizing antibodies, followed by a delayed response dominated by antibodies to NS1. The delayed response to NS1 may be a consequence of its absence from the viral particle, possibly explaining the initial dominance of anti-envelope antibodies. Only after productive ZIKV infection do cells start producing and secreting large amounts of NS1, which then accumulates in bodily fluids and on the surface of infected cells. NS1 circulates in blood, and has been implicated both in damage to endothelial cells and in immune evasion through inhibition of the complement cascade [12, 23, 60, 61] . Of note, antibodies to NS1 have been shown to be protective against Zika and Dengue diseases, and immunization with NS1 has been considered as a possible prophylactic strategy [18, 19, 62 ].

Antibodies to DENV NS1 have also been implicated in pathological autoreactivity in humans [20, 63] . From this perspective, it is interesting to note that reactivity towards selfantigens present in different tissues or cell extracts was observed in the humoral immune response of BALB/c mice to ZIKV infection. The presence of autoreactive antibodies in viral diseases is not an uncommon finding and is often attributed to non-specific polyclonal B cell activation. Autoreactive B cells could be stimulated in a T-independent manner, via simultaneous TLRs and BCR signaling both in GCs and in extrafollicular foci [64-67]. However, polyclonal B lymphocyte activation is mostly an acute phase phenomenon that subsides with clearance of the virus. Here, by contrast, we found that self-reactivity was sustained and even augmented at later time points after infection, long after ZIKV had been eliminated.

Interestingly, NS1-specific antibodies were also long-lasting in serum and correlated well with the kinetics of appearance and maintenance of autoreactive antibodies in BALB/c mice.

Serum IgG isotypes composition of the NS1 specific repertoire was coherent with the sustained IgG anti-NS1 response and with engagement of new clonotypes. Early predominant IgG2a response was followed by a later emergence of IgG1, while IgG2a titers still increased up to 50 days after infection. As previously observed, gamma 1 constant region gene is located upstream of gamma 2a, ruling out sequential switching between these isotypes, implying the recruitment of new clones to sustain anti-NS1 antibody levels. It is still not clear whether the response to the viral antigen is maintained by self-antigens or by the viral antigen itself, that could be present at later time points, even though the virus was not detected after the first week of infection, as long-term antigen persistence in follicular dendritic cells has been well documented [68] . Hence, kinetics of the NS1 response is unique and differs from that induced by viral surface antigens, progressively dominating the humoral response. The shift from antienvelope to anti-NS1 response could be a viral escape strategy, since neutralization is achieved mostly by antibodies directed to viral surface proteins.

Our analysis of GC B cells from ZIKV infected mice revealed both virus-specific and selfreactive B cells. Using single-cell cultures of GC B cells from mice immunized with ZIKV NS1, we showed that both anti-NS1 and autoreactivity could often be attributed to the same cell.

Although GC responses to ZIKV NS1 and DENV NS1 did not differ in kinetics and were of short duration, autoreactive clones were found at all time points investigated after ZIKV NS1 immunization but not after DENV NS1 immunization. It is worth noting that serum IgG anti-ZIKV NS1 did not cross react with DENV NS1, in agreement with the distinct reactivity profiles reported here.

Self-reactive antibodies associated with autoimmune diseases, such as lupus, have been . Notably, a marked glycine enrichment in CDR-H3 was also observed, which might contribute to maintaining the average hydrophobicity close to neutrality. NS1 is a complex multifunctional protein that forms a peculiar hydrophobic core in its hexameric structure which is secreted by infected cells [71] . Interestingly, in addition to the enrichment for charged amino acids, we also found self-reactive clonotypes bearing hydrophobic CDR-H3s; whether these particular clonotypes are able to bind to hydrophobic epitopes on NS1 protein, revealing potential immunogenicity of this hydrophobic core remains to be determined.

Igh sequencing of B cells isolated from GCs of ZIKV NS1 or DENV NS1-immunized mice showed similar usage of VH segments and similar average number of VH mutations, increasing over time as one would expect. However, after ZIKV NS1 immunization, VH mutation numbers were lower among clones found more frequently, possibly indicating selection of neargermline B cell clones. We speculate that this could be due to the availability, in the preimmune repertoire, of B cells able to bind to ZIKV NS1 protein with enough affinity to differentiate rapidly into plasma cells before accumulating many mutations. As recently shown by Burnett and colleagues, selection in GCs is skewed towards lower affinity for self-antigens prior to increasing affinity to foreign antigens [72] . In this context, it is possible that anti-ZIKV NS1 clones could generate plasma cells before acquiring enough mutations to diminish affinity to self-antigens. While it is known that plasma cell differentiation in GCs is dependent on high BCR affinity, the mechanisms through which the affinity threshold for differentiation is set are unclear [73, 74] .

Coupling sequence analysis to binding assays, we found NS1-specific B cells that had similar numbers of VH mutations (higher than those of non-specific clones), regardless of being self-reactive or not. By contrast, self-reactive B cells that did not bind to ZIKV NS1 protein were the least mutated of all and were also not detectably expanded ( Figure 6 G and H) .

These data suggested the presence of antigen-driven selection in spite of self-reactivity, although, among NS1-specific cells, self-reactive cells seemed disfavored as compared to non-self-reactive ones. For instance, the glycine-enriched CDR-H3 ARGGGYDGFAY likely further mutated to ARGGGFDGFAY, generating increased poly-and self-reactivity while simultaneously increasing its reactivity to ZNS1. The autoreactive clonotype ARGTLYAMDY, on the other hand, was found in further mutated versions, ARGTLYTMDY, which lost autoreactivity, and ARGTLYSMDY, which remained autoreactive (Fig. S5 A and Table S1 ).

Overall, our observations suggest that GC B cell clones undergoing selection after ZIKV NS1 immunization tend to be closer to germline than those in DENV NS1 immunization, an intriguing finding that requires further investigation.

In conclusion, we show here, for the first time, that ZIKV NS1-specific GC B cells can cross-react with self-antigens, possibly by molecular mimicry between ZIKV NS1 and selfantigens, raising the question whether self-antigens can participate in the stimulation of anti-NS1 B cell clones. This hypothesis could explain the sustained progression of the anti-NS1 humoral immune response we observed in infected mice, which display similar kinetics to that of self-reactive antibodies in serum. Notably, autoreactive clones that did not react with ZIKV NS1 were also found in GCs, raising the possibility of a "true" break of self-tolerance in the immune response to viral infection that goes beyond antigen mimicry. Finally, the flavivirus NS1 protein has been proven highly immunogenic in humans and capable of inducing protective antibodies and therefore suggested as a potential vaccine antigen [16, 18] or therapeutic antibody target [62] . In this context, the data presented here raise concerns about the safety of that approach and call attention to in-depth analysis of B cell clones engaged in response to this viral antigen, especially in its autoreactive component. This concern is echoed in very recent studies highlighting the self-reactive potential of close-to-germline encoded anti- 

ELISAs to determine serum levels of anti-VLPs, anti-EDIII and anti-NS1 antibodies as well as specificity of IgG in B cell culture supernatants were performed as previously described [35] .

Briefly, 96 well plates (Costar) were coated with peptide (EDIII) (10 µg/ml) or protein (1µg/ml) diluted in PBS and incubated at 4°C for 18h. Serum samples were diluted following serial 

Single GC B cells were sorted into 96-well round-bottom plates containing 3x10 3 NB21 cells/well as previously described with minor modifications, mostly not adding IL-4 [54].

Supernatants were collected after 7 days of culture and cells were frozen in TCL lysis buffer supplemented with 1%β-mercaptoethanol for Igh sequencing.

Single GC B cells from popliteal lymph nodes of Balb/c mice immunized with ZIKV or DENV NS1 proteins were sorted into 96-well PCR plates directly or after 7 days in culture.

Plates contained 5 µl of TCL lysis buffer (Qiagen) supplemented with 1%β-mercaptoethanol.

RNA extraction was performed using SPRI bead as described in [73] . RNA was reverse transcribed into cDNA using an oligo (dT) primer. Igh transcripts were amplified as described in [83] . PCR products were barcoded and sequenced utilizing MiSeq (Illumina) Nano kit v.2 as described in [84] .

Paired-end sequences were assembled with PandaSeq [85] and processed with the FASTX toolkit. The resulting demultiplexed and collapsed reads were assigned to wells according to barcodes. High-count sequences for every single cell/well were analyzed. Ig heavy chains were aligned to both IMGT [86] and Vbase2 [87] databases, in case of discrepancy IgBLAST was used. VH mutation analyses were restricted to cells with productively rearranged Igh genes, as described in [84] . CDR-H3 analyses were performed as described in [88] . Average hydrophobicity of CDR-H3 was calculated as previously described in [89] . Functional rearrangements were grouped by clonotypes defined by the same VH and JH segment and identical CDR-H3 length and amino acid sequence.

Statistical analyses were performed using GraphPadPrism 7.0 software. Tests were chosen according to the type of variable and indicated in each result. Results with p> 0.05 were considered significant.

Principal component analysis (PCA) was performed to compare the repertoires globally.

Reactivity sections were defined and signal intensities across the sections were quantified and analyzed as described in [90] .

Hassert Supernatants that revealed the presence of IgG were tested for antigen specificity by ELISA (F and G) or immunoblot against mouse brain tissue as source of self-antigens (H). 

F -4 -2 0 2 4 R K N D Q E H P Y W S T G A M C F L V I 14 d.p.i. Difference (Percent) DNS1 ZNS1 -4 -2 0 2 4 R K N D Q E H P Y W S T G A M C F L V I 21 d.p.i. -4 -2 0 2 4 R K N D Q E H P Y W S T G A M C F L V

Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections

Complexities in the relationship between infection and autoimmunity

Dengue virus activates polyreactive, natural IgG B cells after primary and secondary infection

Prevalence of Guillain-Barré syndrome among Zika virus infected cases: a systematic review and meta-analysis

Infection-related microcephaly after the 2015 and 2016 Zika virus outbreaks in Brazil: a surveillance-based analysis

Anti-GM1 IgG antibodies in Guillain-Barré syndrome: fine specificity is associated with disease severity

Flavivirus NS1 structures reveal surfaces for associations with membranes and the immune system

Extended surface for membrane association in Zika virus NS1 structure

Predicting Zika virus structural biology: Challenges and opportunities for intervention

An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients

Zika virus NS1, a pathogenicity factor with many faces

Flavivirus NS1 Triggers Tissue-Specific Vascular Endothelial Dysfunction Reflecting Disease Tropism

Mapping Putative B-Cell Zika Virus NS1 Epitopes Provides Molecular Basis for Anti-NS1 Antibody Discrimination between Zika and Dengue Viruses

Delayed and highly specific antibody response to nonstructural protein 1 (NS1) revealed during natural human ZIKV infection by NS1-based capture ELISA

Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection

Cooperation between CD4+ T Cells and Humoral Immunity Is Critical for Protection against Dengue Using a DNA Vaccine Based on the NS1 Antigen

Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease

Antibodies Elicited by an NS1-Based Vaccine Protect Mice against Zika Virus. mBio

Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination

Dengue Virus Nonstructural Protein 1-Induced Antibodies Cross-React with Human Plasminogen and Enhance Its Activation

Relative contribution of nonstructural protein 1 in dengue pathogenesis

The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis

The Dual Role of the Antibody Response Against the Flavivirus Non-structural Protein 1 (NS1) in Protection and Immuno-Pathogenesis

Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease

A Mouse Model of Zika Virus Pathogenesis

Mouse models of dengue virus infection and disease

Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity

B lymphocyte sensitivity to IgM receptor ligation is independent of maturation stage and locally determined by macrophage-derived IFN-beta

Role of type I interferons in the activation of autoreactive B cells

Interferon-driven deletion of antiviral B cells at the onset of chronic infection

Adaptive Immune Responses to Zika Virus Are Important for Controlling Virus Infection and Preventing Infection in Brain and Testes

Analysis of the T Cell Response to Zika Virus and Identification of a Novel CD8+ T Cell Epitope in Immunocompetent Mice

CD8(+) T Cell Immune Response in Immunocompetent Mice during Zika Virus Infection

Structures of the Zika Virus Envelope Protein and Its Complex with a Flavivirus Broadly Protective Antibody

Critical role of CD4+ T cells and IFNγ signaling in antibodymediated resistance to Zika virus infection

Restricted Clonality and Limited Germinal Center Reentry Characterize Memory B Cell Reactivation by Boosting

PANDAseq: paired-end assembler for illumina sequences

IMGT, the international ImMunoGeneTics information system

VBASE2, an integrative V gene database

Development of the expressed Ig CDR-H3 repertoire is marked by focusing of constraints in length, amino acid use, and charge that are first established in early B cell progenitors

A simple method for displaying the hydropathic character of a protein

Invariance and restriction toward a limited set of self-antigens characterize neonatal IgM antibody repertoires and prevail in autoreactive repertoires of healthy adults

We thank Dr. Orlando Ferreira for kindly providing ZIKV and DENV EDIII recombinant proteins; Dr. Edgar F.O. de Jesus (in memoriam) and his lab members for cell irradiation and